glp 1 type 2 diabetes GLP-1 Receptor Agonists as Treatments for GLP-1RAs Reduce External Eating Behavior

A 2024 RCT found semaglutide reduced hip bone density by 2.6% and lumbar spine by 2.1% in one year

A recent study shows interesting effects of GLP1 to support liver health in people with fatty liver.

And its not just about smaller portions

Declining GLP-1 drug prices reveals how selling directly to consumers makes health care more affordable.

As federal regulators intensify enforcement against companies selling unauthorized knockoffs of blockbuster weight-loss drugs, a new Pacific Research Institute brief warns that the booming GLP-1 knockoff market is creating patient safety risks while undermining future breakthrough medicines